SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024749
Filing Date
2022-11-14
Accepted
2022-11-14 08:44:35
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymtx-20220930.htm   iXBRL 10-Q 3320438
2 EX-31.1 ymtx-ex31_1.htm EX-31.1 21841
3 EX-31.2 ymtx-ex31_2.htm EX-31.2 21928
4 EX-32.1 ymtx-ex32_1.htm EX-32.1 27022
  Complete submission text file 0000950170-22-024749.txt   9635753

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ymtx-20220930_pre.xml EX-101.PRE 371982
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ymtx-20220930_def.xml EX-101.DEF 243335
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ymtx-20220930_lab.xml EX-101.LAB 526246
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ymtx-20220930.xsd EX-101.SCH 59509
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ymtx-20220930_cal.xml EX-101.CAL 56977
56 EXTRACTED XBRL INSTANCE DOCUMENT ymtx-20220930_htm.xml XML 1502861
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 221380708
SIC: 2834 Pharmaceutical Preparations